Brief: Iterum Therapeutics Announces Issuance Of Allowance For U.S. Patent Covering Oral Sulopenem
15/12/2022 13:56
Dec 15 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS ANNOUNCES ISSUANCE OF ALLOWANCE FOR A
U.S.
PATENT COVERING ORAL SULOPENEM
Source text for Eikon: ID:nGNX7wMyCH
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity